SPRO
Spero Therapeutics, Inc. Common StockstockNASDAQ
At CloseNov 18, 2026 3:59:43 PM EST
0.87USD-3.362%(-0.03)273,001
Pre-marketNov 18, 2026 9:17:30 AM EST
0.9167USD+1.709%(+0.0154)
After-hoursNov 18, 2026 4:00:30 PM EST
0.874USD+0.344%(+0.003)
Loading…
Loading…
50.75M
Healthcare
Biotechnology
CEO
Ankit Mahadevia
HQ
Cambridge, MA, USA
Previous Close
$0.90
Beta
1.50
52-Week High
$3.08 2026-05-27
52-Week Low
$0.88 2026-11-17
SMA 50
$1.13
SMA 200
$1.90
Avg. Vol 10D
345,970
Avg. Vol 30D
367,358
Avg. Vol 90D
948,302
Relative Vol
0.74
58.26M
47.14M
80.91%
787,025
1.67%
2.23
49%/51%
58.60%
44.43%
0.4100%
3,800,000
1,111
25,556
50,000
41.6M
-29.5M
-67.31
-216.41
Nov 12, 2026
Spero Therapeutics GAAP EPS of -$0.76 misses by $0.62 ·
Seeking Alpha
Nov 10, 2026
Nov 9, 2026
SPRO Profile
spero therapeutics is focused on the development of novel therapies to treat highly resistant bacterial infections. the culture at spero is one of respect, action, collaboration and transparency. spero team members are leaders in the field, and have the ability and desire to be a part of a team. at spero, a feeling that we are part of something groundbreaking and innovative fuels our approach.
SPRO Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.02 | 2026-11-11 | -14.61% | 2.929 |
| 1M | 1.12 | 2026-10-19 | -22.23% | 1.697 |
| 3M | 1.20 | 2026-08-18 | -27.42% | 1.722 |
| 6M | 2.58 | 2026-05-18 | -66.24% | 1.803 |
| 1Y | 2.47 | 2025-11-18 | -64.74% | 1.497 |
| 2Y | 1.14 | 2024-11-18 | -23.60% | — |
| 5Y | 16.39 | 2021-11-18 | -94.69% | 0.803 |
SPRO Stock Summary
Spero Therapeutics, Inc. Common Stock (NASDAQ:SPRO) stock price today is $0.87, and today's volume is 273,023. SPRO is down 3.362% today. The 30 day average volume is 367,358. SPRO market cap is $50.75M with 58.26M shares outstanding.
